Financial Management Professionals Inc. Trims Holdings in SPDR S&P Biotech ETF $XBI

Financial Management Professionals Inc. lessened its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 62.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 367 shares of the exchange traded fund’s stock after selling 605 shares during the period. Financial Management Professionals Inc.’s holdings in SPDR S&P Biotech ETF were worth $30,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. JPMorgan Chase & Co. increased its holdings in shares of SPDR S&P Biotech ETF by 625.1% during the 1st quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock valued at $840,983,000 after purchasing an additional 12,344,558 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in SPDR S&P Biotech ETF by 33.0% in the first quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock valued at $1,096,866,000 after buying an additional 3,353,029 shares in the last quarter. Simplex Trading LLC increased its holdings in SPDR S&P Biotech ETF by 116.1% in the first quarter. Simplex Trading LLC now owns 241,039 shares of the exchange traded fund’s stock valued at $19,548,000 after buying an additional 1,741,445 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. purchased a new position in SPDR S&P Biotech ETF in the first quarter valued at $85,155,000. Finally, Harel Insurance Investments & Financial Services Ltd. purchased a new position in SPDR S&P Biotech ETF in the first quarter valued at $48,660,000.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $95.86 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $105.47. The company has a fifty day moving average of $90.44 and a two-hundred day moving average of $84.58. The stock has a market capitalization of $5.22 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.